340: Crisis in CRISPR world, RFK Jr.'s promises, and a novel non-opioid pain drug
The Readout Loud
Pharmaceutical Earnings Insights and Market Reactions
This chapter explores the latest earnings reports from leading pharmaceutical companies, emphasizing the success of obesity treatments at Eli Lilly and Novo Nordisk. It also examines challenges faced by Amgen and Merck, highlighting the impact of the FDA's actions and market reactions on their products.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
